GlassScriptPhysician profile
David P Roberge
NPI 1932322989
$28,494.97
in general payments reported to CMS, 2019-2025
5 companies · $6,476 in 2025
The $6,476 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,366 · 2022: $12K · 2024: $5,503 · 2025: $6,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Honoraria: $923 · Travel and Lodging: $716 · Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,144.17 |
| Honoraria | $922.72 |
| Travel and Lodging | $716.33 |
| Food and Beverage | $195.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $14,350.12 | 2021-2022 | |
| Novocure INC. | $11,978.61 | 2024-2025 | |
| Kyowa Kirin, INC. | $1,590.83 | 2021 | |
| Zap Surgical Systems, INC. | $500.00 | 2021 | |
| Gt Medical Technologies, INC | $75.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Roberge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.